Table 2. Inpatient expenses of cancer in China during 2008−2017.
| Variables | Inpatient expenses (×100 million) (CNY) | Overall
change (%) |
APC (95% CI) (%) | ||||||||||
| 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2008−2013 | 2013−2017 | ||
| CNY, Chinese Yuan; APC, annual percentage change; 95% CI, 95% confidence interval. | |||||||||||||
| Overall | 514.6 | 637.4 | 804.3 | 1,002.2 | 1,190.1 | 1,526.4 | 1,710.9 | 1,926.0 | 2,185.0 | 2,419.4 | 370.2 | 21.5 (20.3, 22.7) | 11.7 (11.0, 12.3) |
| By subtypes | |||||||||||||
| Nasopharynx cancer | 9.5 | 13.0 | 17.1 | 21.3 | 23.9 | 28.5 | 29.3 | 35.2 | 31.4 | 31.1 | 227.4 | 21.5 (16.5, 26.6) | 2.4 (−5.9, 10.8) |
| Esophagus cancer | 34.9 | 41.3 | 57.9 | 73.9 | 86.0 | 113.0 | 124.0 | 126.6 | 139.8 | 149.7 | 328.9 | 23.8 (20.6, 26.9) | 6.8 (4.8, 8.8) |
| Stomach cancer | 55.0 | 76.2 | 91.4 | 114.4 | 134.2 | 181.6 | 185.6 | 193.8 | 222.6 | 238.4 | 333.5 | 22.6 (19.4, 25.7) | 7.3 (3.5, 11.0) |
| Colorectal cancer | 62.0 | 79.4 | 98.4 | 124.6 | 158.0 | 197.7 | 225.7 | 256.5 | 287.4 | 323.3 | 421.5 | 23.1 (22.7, 23.6) | 12.3 (11.5, 13) |
| Liver cancer | 44.9 | 53.8 | 64.2 | 80.5 | 92.8 | 144.6 | 176.6 | 164.7 | 178.3 | 202.9 | 351.9 | 22.0 (16.3, 27.7) | 6.9 (0, 13.8) |
| Gallbladder carcinoma | 3.6 | 4.6 | 5.5 | 7.8 | 8.1 | 10.9 | 11.8 | 12.9 | 14.3 | 16.0 | 344.4 | 21.7 (17.3, 26.1) | 9.6 (8.4, 10.8) |
| Pancreatic cancer | 11.8 | 14.4 | 18.2 | 22.9 | 26.5 | 33.8 | 36.1 | 39.4 | 47.2 | 52.9 | 348.3 | 20.9 (19.3, 22.5) | 11.6 (7.9, 15.4) |
| Lung cancer | 89.0 | 109.9 | 142.2 | 174.8 | 208.8 | 281.2 | 313.6 | 355.9 | 395.6 | 460.3 | 417.2 | 22.5 (20.6, 24.5) | 12.2 (10.8, 13.5) |
| Breast cancer | 32.8 | 38.6 | 51.3 | 62.9 | 75.1 | 95.1 | 107.3 | 115.7 | 135.6 | 144.9 | 341.8 | 21.5 (19.6, 23.4) | 10.8 (8.4, 13.1) |
| Cervical cancer | 14.5 | 18.3 | 21.9 | 28.5 | 35.2 | 56.0 | 59.1 | 70.0 | 89.7 | 83.7 | 477.2 | 25.7 (19.9, 31.4) | 12.2 (3.5, 20.9) |
| Ovarian cancer | 8.8 | 10.7 | 14.0 | 17.3 | 20.2 | 27.8 | 29.5 | 33.2 | 38.7 | 40.8 | 363.6 | 22.5 (19.9, 25) | 10.4 (7.3, 13.4) |
| Prostatic cancer | 7.1 | 9.3 | 10.7 | 14.1 | 17.8 | 21.5 | 27.1 | 33.9 | 36.5 | 42.1 | 493.0 | 22.2 (20.0, 24.3) | 16.4 (10.6, 22.3) |
| Bladder cancer | 10.5 | 13.6 | 15.3 | 19.3 | 23.9 | 27.9 | 32.8 | 39.8 | 43.5 | 50.1 | 377.1 | 19.5 (17.3, 21.6) | 14.5 (11.5, 17.6) |
| Brain cancer | 13.5 | 15.9 | 18.6 | 22.4 | 25.0 | 37.3 | 41.1 | 43.8 | 56.3 | 67.0 | 396.3 | 18.9 (13.7, 24.2) | 14.9 (8.5, 21.2) |
| Thyroid cancer | 8.6 | 10.8 | 10.7 | 15.5 | 22.0 | 33.5 | 46.8 | 56.2 | 70.3 | 89.5 | 940.7 | 26.6 (16.7, 36.4) | 23.7 (19.6, 27.8) |
| Leukemia | 38.2 | 50.2 | 51.4 | 63.7 | 71.5 | 111.8 | 124.5 | 126.5 | 168.0 | 169.2 | 342.9 | 19.0 (11.6, 26.4) | 11.3 (4.1, 18.5) |
| Others | 69.9 | 77.6 | 115.6 | 138.3 | 161.1 | 124.3 | 140.2 | 221.9 | 229.9 | 257.7 | 268.7 | 15.0 (2.2, 27.8) | 19.5 (7.4, 31.6) |
| By types of hospital | |||||||||||||
| General, grade 2 | 93.0 | 115.2 | 143.5 | 163.4 | 166.8 | 198.7 | 209.5 | 218.2 | 215.6 | 230.1 | 147.4 | 14.4 (9.8, 19.0) | 3.2 (1.2, 5.3) |
| General, grade 3 | 283.8 | 353.9 | 453.6 | 574.2 | 703.2 | 924.1 | 1,046.0 | 1,197.6 | 1,402.1 | 1,559.3 | 449.4 | 23.4 (22.4, 24.5) | 13.4 (12.1, 14.7) |
| Cancer specialized | 87.7 | 108.0 | 132.9 | 170.8 | 213.3 | 261.1 | 305.6 | 350.0 | 389.3 | 419.4 | 378.2 | 22.1 (21.2, 23.0) | 11.9 (8.9, 14.9) |
| Others | 50.1 | 60.3 | 74.3 | 93.8 | 106.8 | 142.5 | 149.8 | 160.2 | 178.0 | 210.6 | 320.4 | 20.5 (18.3, 22.7) | 9.5 (5.2, 13.9) |
| By regions | |||||||||||||
| East China | 333.6 | 403.1 | 509.0 | 620.8 | 719.5 | 884.9 | 1,004.9 | 1,147.7 | 1,326.0 | 1,443.4 | 332.7 | 19.5 (18.0, 21.0) | 12.6 (10.8, 14.3) |
| Middle China | 123.4 | 158.7 | 200.5 | 258.6 | 327.6 | 427.0 | 470.5 | 522.4 | 577.8 | 664.2 | 438.2 | 24.7 (24.1, 25.2) | 10.9 (9.5, 12.3) |
| West China | 57.5 | 75.6 | 94.8 | 122.9 | 142.9 | 214.5 | 235.5 | 255.9 | 281.2 | 311.8 | 442.3 | 25.0 (21.2, 28.8) | 9.3 (8.6, 9.9) |